Concepedia

Lesley Schofield

LS

7

Publications

525

Citations

7

H-Index

1997

Active since

Affiliations

Novartis (United States)(Current)

Neurology Associates

Urology Associates

University of California, San Francisco

University of California, Irvine

Lesley Schofield is an author at Novartis (United States) specializing in clinical trials, medicine, and multiple sclerosis.

Top concepts

Publications per year

1997–2023

7

Publications

7

Role for Bcl-x<sub>L</sub>as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis

Surender Kharbanda, Pramod S. Pandey, Lesley Schofield et al. · Proceedings of the National Academy of Sciences · 1997 · 397 citations · Full text

Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

Joel M. Neutel, David H.G. Smith, Michael A. Weber et al. · Journal of Clinical Hypertension · 2005 · 52 citations · Full text

Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial

Bruce Cree, Douglas L. Arnold, Mark Cascione et al. · Therapeutic Advances in Neurological Disorders · 2018 · 23 citations · Full text

Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank

Shanti Narayanasamy, Lesley H. Curtis, Adrian F. Hernandez et al. · Clinical Infectious Diseases · 2023 · 18 citations · Full text

First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis

Bruce Hughes, Mark Cascione, Mark S. Freedman et al. · Multiple Sclerosis and Related Disorders · 2014 · 13 citations

, , +8

Rows per page

1–5 of 7